The efficacy and safety of cold snare polypectomy with submucosal injection for the removal of polyps less than 20 mm in size: a systematic review and meta‐analysis

Abstract

AbstractBackground and AimNeoplastic polyp removal is important for colorectal cancer prevention. Endoscopists have proposed cold snare endoscopic mucosal resection (CS‐EMR) as a solution to solve positive cutting edges and postoperative bleeding. However, many controversies regarding its specific performance in practice have been reported. The aim of this pooled analysis was to report the efficacy and safety of CS‐EMR.MethodsPubMed/Medline, Embase, Google Scholar, and the Cochrane Library searched up to January 2022 to identify studies in which CS‐EMR was performed for the removal of colorectal polyps measuring less than 20 mm. The primary outcome was the complete resection rate (CRR), and the secondary outcome was the rate of adverse events.ResultsEleven studies were included in the final analysis, which included 861 colorectal polyps. The overall CRR with CS‐EMR was 96.3% (95% CI, 93.9–98.2%). The early and delayed bleeding rates of CS‐EMR were 3.1% (95% CI, 1.2–5.5%) and 1.4% (95% CI, 0.6–2.4%), respectively. There were no statistical significances between CS‐EMR and cold snare polypectomy (CSP) in terms of the CRR and adverse events, as well as CS‐EMR and hot snare endoscopic mucosal resection (HS‐EMR).ConclusionsFor resecting colorectal polyps measuring ≤20 mm, CS‐EMR is an effective attempt. However, compared with CSP and HS‐EMR, CS‐EMR did not improve the efficiency and safety of polypectomy as expected. Multicenter randomized controlled trials are needed to compare CSP with CS‐EMR in the resection of <10 mm polyps and HSP with CS‐EMR in the resection of ≥10 mm polyps.